To that end, we used GEPIA (Gene Expression Profiling Interactive Analysis), a web-based tool (uses TCGA and GTEx dataset) to determine the relationship between aberrant OMA1 mRNA levels with the expression of some of the common EMT marker genes in human breast cancer (Fig. 1C,D). This evidence concerns the gene OMA1 and breast carcinoma.